Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Nemaura Medical Inc - SIC # 3842 - ORTHOPEDIC, PROSTHETIC, AND SURGICAL APPLIANCES AND SUPPLIES
Ticker
Exchange
SIC #
Website
Latest Ticker
NMRD
Over the counter
3842
https://nemauramedical.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Nemaura Medical Inc
Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET
- Jan 22nd, 2024 9:15 pm
Important Update on Listing Status and Strategic Direction
- Jan 3rd, 2024 12:00 pm
Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision
- Dec 13th, 2023 1:00 pm
Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth
- Nov 21st, 2023 1:30 pm
Nemaura (NMRD) to Expand in UK With Metabolic Health Program
- Nov 17th, 2023 4:41 pm
Nemaura Medical First Half 2024 Earnings: US$0.13 loss per share (vs US$0.33 loss in 1H 2023)
- Nov 16th, 2023 10:16 am
Sidoti Events, LLC’s Virtual November Micro-Cap Conference
- Nov 14th, 2023 1:55 pm
Nemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss Drugs
- Nov 14th, 2023 1:00 pm
Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update
- Nov 13th, 2023 9:14 pm
Nemaura Medical Announces Appointment of Mr Nikolai Rozanov as Strategic Adviser in Artificial Intelligence, to Assist in Development of its AI Health Coach, and Strengthen Outcomes in its CGM Based Metabolic and Type 2 Diabetes Programs.
- Sep 26th, 2023 1:50 pm
Maxim Group LLC to Host the Virtual Tech Conference Series: Emerging Growth in A.I., on Tuesday, September 26th & Wednesday, September 27th at 8:00 A.M. ET.
- Sep 22nd, 2023 7:05 pm
Nemaura Medical to Present at the Maxim Group Emerging Growth in A.I. Conference
- Sep 18th, 2023 1:15 pm
Nemaura Medical Provides Update on Nasdaq Compliance Status and Process
- Sep 14th, 2023 12:00 pm
Nemaura Medical Announces Interim Results from its Collaboration with the UK’s National Health Service on its Metabolic Health & Weight Loss Program
- Sep 13th, 2023 12:00 pm
Nemaura Medical Announces Participation at HLTH 2023, Las Vegas
- Sep 12th, 2023 1:26 pm
Nemaura Medical, Inc. (NMRD) Upgraded to Buy: What Does It Mean for the Stock?
- Aug 23rd, 2023 4:00 pm
Nemaura Medical Announces SFDA Approval of sugarBEAT®
- Aug 17th, 2023 12:30 pm
Nemaura Medical Reports Fiscal First Quarter 2024 Results and Provides Business Update
- Aug 14th, 2023 12:30 pm
Nemaura Medical Secures $6.5m in Non-Dilutive Funding
- Aug 11th, 2023 8:05 pm
Nemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2023
- Jul 14th, 2023 1:25 pm
Scroll